awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q36141619-14FD15F6-5568-49B7-911C-9255BEC9CF0F
Q36141619-14FD15F6-5568-49B7-911C-9255BEC9CF0F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36141619-14FD15F6-5568-49B7-911C-9255BEC9CF0F
Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.
P2860
Q36141619-14FD15F6-5568-49B7-911C-9255BEC9CF0F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36141619-14FD15F6-5568-49B7-911C-9255BEC9CF0F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fba62146439c9a2d5a75e6bc3726c0b114612491
P2860
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.